Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

AB5905 Anti-Vesicular Glutamate Transporter 1 Antibody

AB5905
50 µL  
Purchase on Sigma-Aldrich

Offerte speciali

Panoramica

Replacement Information

Offerte speciali

Tabella delle specifiche principali

Species ReactivityKey ApplicationsHostFormatAntibody Type
RIH(P), ICCGpSerumPolyclonal Antibody
Description
Catalogue NumberAB5905
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Vesicular Glutamate Transporter 1 Antibody
Alternate Names
  • VGLUT1
  • BNPI
Background InformationVGLUT1 is expressed in a subset of glutamate neurons and transports glutamate into native synaptic vesicles from the brain, exhibiting a conductance for chloride that is blocked by glutamate. Vesicular glutamate transport has a substantially lower apparent affinity than the plasma membrane excitatory amino acid transporters. Glutamate transport by VGLUT1 is saturated with a K(m) of approximately 2 mM, in the same range as transport by synaptic vesicles. Finally, plasma membrane glutamate transporters recognize both aspartate and glutamate as substrates, whereas VGLUT1 does not recognize aspartate.
References
Product Information
FormatSerum
Control
  • Rat brain lysate
PresentationGuinea Pig polyclonal antiserum with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationThis guinea pig polyclonal Anti-Vesicular Glutamate Transporter 1, Cat. No. AB5905 is tested for use in Immunohistochemistry (Paraffin) and Immunocytochemistry, for the detection of Vesicular glutamate transporter 1-VGluT1.
Key Applications
  • Immunohistochemistry (Paraffin)
  • Immunocytochemistry
Application NotesTested Applications

Immunocytochemistry Analysis: A 1:250 dilution from a representative lot detected Vesicular Glutamate Transporter 1 in rat E18 cortical cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Biological Information
ImmunogenSynthetic peptide from rat VGLUT1 protein with no overlap to VGLUT2. The immunogen is available as AG208.
ConcentrationVariable
HostGuinea Pig
SpecificityRecognizes Vesicular Glutamate Transporter 1 (VGLUT1, BNPI {Brain specific Na+ dependent inorganic phosphate cotransporter}). The antiserum has been tested on tissue sections from the rat central nervous system (CNS) using immunofluorescence histochemistry. The antiserum mainly labels nerve fibers and terminals. VGLUT1 is an excellent marker for glutamatergic nerve terminals. The staining pattern for the staining obtained with the VGLUT1 antiserum corresponds to the pattern described using other antisera to VGLUT1 (Bellocchio et al., 1998; Fremeau et al., 2001; Fujiyama et al., 2001; Sakata-Haga et al., 2001; Tong et al., 2001; Kaneko et al. 2002; Varoqui et al., 2002). Preabsorption of the VGLUT1 antiserum with immunogen peptide eliminates all immunostaining.
Species Reactivity
  • Rat
Species Reactivity NoteRat. Predicted to react with Mouse, Bovine based on 100% sequence homology.
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene Summarya Na(+)-dependent inorganic phosphate cotransporter.
Gene Symbol
  • VGluT1
  • Solute carrier family 17 member 7
  • Brain-specific Na(+)-dependent inorganic phosphate cotransporter
  • Slc17a7
  • Bnpi
Purification MethodUnpurified
UniProt Number
UniProt SummaryFUNCTION: SwissProt: Mediates the uptake of glutamate into synaptic vesicles at presynaptic nerve terminals of excitatory neural cells. May also mediate the transport of inorganic phosphate.
SIZE: 560 amino acids; 61665 Da [MW of unprocessed precursor]
SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane. Membrane; Multi-pass membrane protein (Potential). Cell junction, synapse, synaptosome.
TISSUE SPECIFICITY: Expressed in the cerebellum, cerberal cortex and hippocampus. Isoform 2 is expressed specifically in retina.
SIMILARITY: Belongs to the major facilitator superfamily. Sodium/anion cotransporter family. VGLUT subfamily.
Molecular Weight62 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Immunohistochemistry (Paraffin) in rat brain hippocampal tissue sections.

Immunohistochemistry (Paraffin) Analysis: A 1:2,000 dilution of this antibody detected Vesicular Glutamate Transporter 1 in rat brain hippocampal tissue sections.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStore at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size50 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
AB5905 04053252333897

Documentation

Anti-Vesicular Glutamate Transporter 1 Antibody MSDS

Titolo

Scheda di sicurezza (MSDS) 

Anti-Vesicular Glutamate Transporter 1 Antibody Certificati d'Analisi

TitoloNumero di lotto
Anti-VGLUT1 - 2370733 2370733
Anti-VGLUT1 - 2387528 2387528
Anti-VGLUT1 - 2430498 2430498
Anti-VGLUT1 - 2455644 2455644
Anti-VGLUT1 - 3193844 3193844
Anti-VGLUT1 - 3258729 3258729
Anti-VGLUT1 - 3308226 3308226
Anti-VGLUT1 - 3478256 3478256
Anti-VGLUT1 - 3616495 3616495
Anti-VGLUT1 - 3756537 3756537

Riferimenti bibliografici

Panoramica dei riferimenti bibliograficiApplicazioneSpecieCodice d'identificazione nel Pub Med
Aberrant synaptic integration in adult lamina I projection neurons following neonatal tissue damage.
Li, J; Kritzer, E; Craig, PE; Baccei, ML
The Journal of neuroscience : the official journal of the Society for Neuroscience  35  2438-51  2015

Mostra il sommario
25673839 25673839
Cis and trans RET signaling control the survival and central projection growth of rapidly adapting mechanoreceptors.
Fleming, MS; Vysochan, A; Paixão, S; Niu, J; Klein, R; Savitt, JM; Luo, W
eLife  4  e06828  2015

Mostra il sommario
25838128 25838128
Mapping synapses by conjugate light-electron array tomography.
Collman, F; Buchanan, J; Phend, KD; Micheva, KD; Weinberg, RJ; Smith, SJ
The Journal of neuroscience : the official journal of the Society for Neuroscience  35  5792-807  2015

Mostra il sommario
25855189 25855189
Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity.
Atkin, G; Moore, S; Lu, Y; Nelson, RF; Tipper, N; Rajpal, G; Hunt, J; Tennant, W; Hell, JW; Murphy, GG; Paulson, H
The Journal of neuroscience : the official journal of the Society for Neuroscience  35  6165-78  2015

Mostra il sommario
25878288 25878288
Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture.
Paşca, AM; Sloan, SA; Clarke, LE; Tian, Y; Makinson, CD; Huber, N; Kim, CH; Park, JY; O'Rourke, NA; Nguyen, KD; Smith, SJ; Huguenard, JR; Geschwind, DH; Barres, BA; Paşca, SP
Nature methods  12  671-8  2015

Mostra il sommario
26005811 26005811
Adolescent intermittent alcohol exposure: persistence of structural and functional hippocampal abnormalities into adulthood.
Risher, ML; Fleming, RL; Risher, WC; Miller, KM; Klein, RC; Wills, T; Acheson, SK; Moore, SD; Wilson, WA; Eroglu, C; Swartzwelder, HS
Alcoholism, clinical and experimental research  39  989-97  2015

Mostra il sommario
25916839 25916839
Loss of δ-catenin function in severe autism.
Turner, TN; Sharma, K; Oh, EC; Liu, YP; Collins, RL; Sosa, MX; Auer, DR; Brand, H; Sanders, SJ; Moreno-De-Luca, D; Pihur, V; Plona, T; Pike, K; Soppet, DR; Smith, MW; Cheung, SW; Martin, CL; State, MW; Talkowski, ME; Cook, E; Huganir, R; Katsanis, N; Chakravarti, A
Nature  520  51-6  2015

Mostra il sommario
25807484 25807484
Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.
Puccini, JM; Marker, DF; Fitzgerald, T; Barbieri, J; Kim, CS; Miller-Rhodes, P; Lu, SM; Dewhurst, S; Gelbard, HA
The Journal of neuroscience : the official journal of the Society for Neuroscience  35  5271-83  2015

Mostra il sommario
25834052 25834052
Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies.
Peng, X; Hughes, EG; Moscato, EH; Parsons, TD; Dalmau, J; Balice-Gordon, RJ
Annals of neurology  77  381-98  2015

Mostra il sommario
25369168 25369168
Inner retinal change in a novel rd1-FTL mouse model of retinal degeneration.
Greferath, U; Anderson, EE; Jobling, AI; Vessey, KA; Martinez, G; de Iongh, RU; Kalloniatis, M; Fletcher, EL
Frontiers in cellular neuroscience  9  293  2015

Mostra il sommario
26283925 26283925